While fibroid removal surgery is not a popular topic on this site simply because there are so many other ways that you can use if you are battling uterine fibroids, some women do choose surgery and in some cases, surgery may be the best option.
If you are considering the use of fibroid removal surgery, the FDA issued a news release on April 17, 2014 warning against the use of the following surgical procedure for uterine fibroid removal.
In a safety communication notice issued today, the U.S. Food and Drug Administration discouraged the use of laparoscopic power morcellation for the removal of the uterus (hysterectomy) or uterine fibroids (myomectomy) in women because, based on an analysis of currently available data, it poses a risk of spreading unsuspected cancerous tissue, notably uterine sarcomas, beyond the uterus.
For those who don’t know what the laparoscopic power morcellation procedure is the following description from OBG Management explains it a little bit.
Laparoscopic surgeons often select open power morcellation of the fibroid or fibroid-laden uterus to remove the mass of tissue through a small laparoscopy port. In current MIGS practice, power morcellation typically occurs outside of a closed environment, such as a bag.
A morcellation represents the use of a device known as a morcellator which is a surgical instrument that is used for the division and removal of large masses of tissues such as fibroid tumors during a laparoscopic surgical procedure. This article also goes on to say that one of the drawbacks of this procedure is as follows;
Open power morcellation of uterine tissue has an important pitfall. This practice permits small bits of tissue to spread around the peritoneal cavity… Given the enhanced growth potential of uterine tumor cells, the postoperative growth of nodules of tissue generated by morcellation is a worrisome possibility.
Open morcellation of uterine fibroids may result in the dispersion of bits of tissue around the peritoneal cavity and surgical ports. If the fibroid contains genetic mutations that significantly increase the growth potential of fibroid cells, fibroid nodules may grow postoperatively in the pelvis, abdomen, and surgical ports.5–15 Investigators have called these disseminated nodules of fibroid tumor, “morcellomas.”16
Article Source: Click here to read more
The news release from the FDA goes on to say that they discourage the use of this procedure effective immediately because their research has shown the following.
Based on an analysis of currently available data, the FDA has determined that approximately 1 in 350 women who are undergoing hysterectomy or myomectomy for fibroids have an unsuspected type of uterine cancer called uterine sarcoma. If laparoscopic power morcellation is performed in these women, there is a risk that the procedure will spread the cancerous tissue within the abdomen and pelvis, significantly worsening the patient’s likelihood of long-term survival.
Article source: Read more of the FDA news release
It is important to remember that the FDA has no problem with certain fibroid removal surgery procedures such as the myomectomy, hysterectomy, etc.
If you are dead set about using fibroid removal surgery, in your discussions with your doctor, do ensure that there are no FDA warnings about any procedures you choose.
If on the other hand you want to know what natural methods you can use to eliminate fibroids naturally, you must get the Fibroids Miracle step by step guide to freedom from fibroids using natural methods only. Find out more about this bestselling holistic guide here.